The Sunmed™ Control Syringes using dynamics principle, by means of the interference fit between the plunger with piston and the barrel, using the aspirating or driving force generated by manual function to draw or inject angiography medicament or saline for clinical disposable use.
The Sunmed™ Control Syringes is a single-use device that consists of two different structures: one is the standard type; the other is locking plunger type.
The volume of two type control syringes that to be offered in 10ml, 12ml.
The sunmed™ Control Syringes are available with rotating male luer and fixed male luer.
The sterilization method of the Sunmed™ Control Syringes is Ethylene Oxide sterilization.

AI/ML Overview

This document is a 510(k) premarket notification for the Sunmed™ Control Syringes. It describes the device and claims substantial equivalence to predicate devices, but it does not describe a study proving the device meets specific acceptance criteria in the context of an AI/algorithm-based medical device.

The document discusses "acceptance criteria" only in a very general sense, referring to standard non-clinical tests for medical devices like biocompatibility, sterility, and bench testing, to demonstrate substantial equivalence to a predicate device. There is no mention of an algorithm, AI, or software performance evaluation.

Therefore, I cannot provide the requested information regarding AI device performance, sample sizes, ground truth establishment, or expert involvement, as these elements are not present in the provided text.

Here's a breakdown of why I cannot fulfill the request based on the provided text:

No AI or Algorithm: The device is a "Sunmed™ Control Syringes," a physical medical device intended to inject contrast media or saline. This is not an AI or algorithm-based device.
No "Device Performance" in the AI sense: The document assesses physical characteristics (pressure rating, clarity, sterility, etc.) against predicate devices, not AI performance metrics like sensitivity, specificity, or AUC.
No Study Design for AI: There's no mention of training sets, test sets, ground truth, expert adjudication, or MRMC studies, all of which are relevant to AI device evaluations.

The document's purpose is to demonstrate substantial equivalence for a physical device, not to evaluate an AI's diagnostic or predictive capabilities.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a series of human profiles.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

November 10, 2016

Sunny Medical Device (Shenzhen) Co., Ltd. James Qi Zhang General Manager 56 Lehigh Aisle Irvine, California 92612

Re: K160190

Trade/Device Name: Sunmed Control Syringes Regulation Number: 21 CFR 870.1650 Regulation Name: Angiographic Injector and Syringe Regulatory Class: Class II Product Code: DXT Dated: September 28, 2016 Received: October 3, 2016

Dear James Qi Zhang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Brian D. Pullin -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K160190

Device Name Sunmed Control Syringes

Indications for Use (Describe)

The Sunmed Control Syringes is intended to inject contrast media or saline for angiographic procedures.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

5. 510(k) Summary(K160190)

1. Submitted by: Sunny Medical Device (Shenzhen) Co., Ltd. Registered Address: 4/F and 5/F, Dongpingxing Creative Science Park, Longgang District, Shenzhen, Guangdong, P.R. China 518172 56 Lehigh Aisle, Irvine, CA 92612 Contact Address:

Telephone:	(949)216-8838
Fax:	(949)423-0168
Contact:	JamesQi Zhang, General Manager
E-mail:	jamesqizhang@gmail.com
Date:	November 9, 2016

2. Proposed Device:

Trade/Proprietary Name:	Sunmed™ Control Syringes
Common/Usual Name:	Control Syringes
Classification:	II
Classification Name:	Angiographic injector and syringe
Regulation Number:	870.1650
Product Code:	DXT

1. Predicate Device:

510(k)Number	Trade Name	Manufacture
K093830	Medline Angiographic ControlSyringes	Medline Industries Inc.
K072696	ANT Angiographic Syringes	Shenzhen Ant Hi-TechIndustrial Co., Ltd.

Note: In the case of other characteristics substantially the same, Mediline Angiographic Control Syringes and our company's product are more similar in the specification model and materials. Medline Angiographic Control Syringes is identified as the primary predicate, which manufactured by Medline Industries Inc.

{4}------------------------------------------------

4. Device description

The Sunmed™ Control Syringes is a single-use device that consists of two different structures: one is the standard type; the other is locking plunger type. The properties of the standard plunger type and locking plunger type are in table below:

Standard plunger Type	Locking Plunger Type
Humanized design, easy and simple operation, can be single hand operation	Humanized design, easy and simple operation, can be single hand operation
The wall of the tube is clear and transparent, the inner surface is smooth, and the promotion is convenient	The wall of the tube is clear and transparent, the inner surface is smooth, and the promotion is convenient
Printing scale is clear and accurate	Printing scale is clear and accurate
Pressure rating: 300 kPa	Locking design improve the security and stability.Pressure rating: 300 kPa

The volume of two type control syringes that to be offered in 10ml, 12ml.

The sunmed™ Control Syringes are available with rotating male luer and fixed male luer. The rotating male luer can be rotated. When connected with the other device, they can rotate freely. While the fixed male luer cannot be rotated. The rotating male luer and fixed male luer both are in line with ISO 594-2:1998.

The sterilization method of the Sunmed™ Control Syringes is Ethylene Oxide sterilization.

1. Intended Use
  The Sunmed™ Control Syringes is intended to inject contrast media or saline for angiographic procedures.

{5}------------------------------------------------

1. Technological Comparison to Predicate Device
  The technological characteristics of the subject device, the Sunmed™ Control Syringes, are equivalent in intended use, materials, operating principle, sterility assurance level, and method of sterilization to the Medline Angiographic Control Syringes; and the Sunmed™ Control Syringes is also similar to the ANT Angiographic Syringes in that it consists of the intended use, operating principle, sterility assurance level, and method of sterilization.
Summary of Non-Clinical Testing 7.
The following tests were performed; the results of the performance testing demonstrated the substantial equivalence of the Sunmed™ Control Syringes.

Biocompatibility Testing: Acute Systemic Toxicity Test (two kinds of solvent) Skin sensitization Test (two kinds of solvent) In Vitro Hemolysis Study Intracutaneous Reactivity Test (two kinds of solvent) In Vitro Cytotoxicity Test

Package Penetrate Testing Asepsis Testing Aging Testing EtO and ECH Residue Testing Bench Testing

1. Clinical Evaluation was not applicable.
1. Conclusions

Based on the information presented in this 510(k) premarket notification, the Sunmed™ Control Syringes is considered substantially equivalent to the Medline Angiographic Control Syringes and ANT Angiographic Syringes.

Regulation Number and Section

§ 870.1650 Angiographic injector and syringe.

(a)
Identification. An angiographic injector and syringe is a device that consists of a syringe and a high-pressure injector which are used to inject contrast material into the heart, great vessels, and coronary arteries to study the heart and vessels by x-ray photography.(b)
Classification. Class II (special controls). The device, when it is a non-patient contacting balloon inflation syringe intended only to inflate/deflate balloon catheters and monitor pressure within the balloon, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.